As a first-time investor, it can be daunting trying to figure out where to put your money. But don’t worry, we’ve got you covered. Join us as we cover different types of investments!

What are the most popular types of investments? | Get Rich Slow Club

Whilst none of us are the next Warren Buffett, we have the ability to "own a piece of America", as he often suggests. For this reason, we're sharing the 10 most most popular US stocks on Pearler. 

Check out Pearler's most popular US stocks

Think of community data as a compass: you can choose any stock you want, but our community keeps pointing in the same general direction - simple, diversified, and cheap ETFs. Let's take a look at the 10 most popular ETFs on Pearler.

These are Pearler's most popular ETFs

iTeos Therapeutics Inc (ITOS:US) Share Price | Pearler

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

The iShares Core S&P Total U.S. Stock Market ETF (the Fund), formerly iShares S&P 1500 Index Fund, seeks investment results that correspond to the price and yield performance, before fees and expences, of the Standard & Poor’s Composite 1500 (the Index). The Index consists of the S&P 500, Midcap 400 and SmallCap 600 indices, which together represent approximately 92% of the total United States equity market. The S&P 500 measures the performance of the large-capitalization sector of the United States equity market. The S&P 400 measures the performance of the mid-capitalization sector of the United States equity market. The Fund will concentrate its investments (that is holds 25% or more of its total assets) in a particular industry or group of industries, which may include large-, mid- or small-capitalization companies. It may also engage in securities lending. BlackRock Fund Advisors (BFA) is the investment adviser of the Fund.

Core S&P Total US Stock Mkt iShares ETF

Itamar Medical Ltd. researches and manufactures medical diagnostic equipment. The Company's products use peripheral arterial tone signals to screen, diagnose, and follow-up on clinical conditions such as endothelial dysfunction, coronary artery disease, chest pain evaluation, congestive heart failure, obstructive sleep apnea, Cheyne-Stokes breathing patterns, and other conditions.

ITAMAR MEDICAL LTD-SPON ADR

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. The Company’s pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, EOS-448, also known as GSK4428859A, is an antagonist of T-cell immunoreceptor with lg and ITIM domains, an immune checkpoint with multiple mechanisms of action. The Company is also advancing inupadenant, a next generation adenosine A2A receptor antagonist tailored to overcome the specific adenosine-mediated immunosuppression. It is investigating inupadenant in an open-label multi-arm Phase I/IIa clinical trial in adult cancer patients with advanced solid tumors.

ITOS

Buy

👑 Overview

📈

-1.13%

Annual Growth

🌏

0

Pearlers Invested

Key information

🔎 Fund Overview

Price History*

Unsure how much or often to invest?

🗓️ Investing frequency calculator

💵 Investing amount calculator

⏱️ Investing duration calculator

💵

6.50 AUD*

Purchase Fee

💼

N/A

Management Fee

💸

Want to know the long term costs?

Calculate the historic long term costs to hold your investments

Technical Info

$18.05

How our community is investing

0

N/A

N/A

N/A

N/A

ITOS investor breakdown

💵 Income of investors

👶 Age of investors

🙋 Legal gender of investors

$92.38 USD

Find Out More

$30.87 USD

Find Out More

Buy